世界の希少疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rare Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4937 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、希少疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オリジネーター医薬品、ジェネリック医薬品）、用途別市場規模（病院薬局、専門薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・希少疾患治療の市場動向 ・企業の競争状況、市場シェア ・希少疾患治療の種類別市場規模（オリジネーター医薬品、ジェネリック医薬品） ・希少疾患治療の用途別市場規模（病院薬局、専門薬局、ドラッグストア） ・希少疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・希少疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・希少疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・希少疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・希少疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Pfizer、F. Hoffmann-La Roche、Celgene、AbbVie、Johnson & Johnson、Takeda、Alexion、Novo Nordisk、Sanofi、Bayer、Amgen、Allergan、Eisai、Bristol-Myers Squibb、Merck、Vertex Pharmaceuticals、Baxter、BioMarin、Teva Pharmaceutical Industries） ・結論

A rare disease is any disease that affects a small percentage of the population.
Most rare diseases are genetic and thus are present throughout the person’s entire life, even if symptoms do not immediately appear.

Market Analysis and Insights: Global Rare Disease Treatment Market
The global Rare Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rare Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rare Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rare Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rare Disease Treatment market.

Global Rare Disease Treatment Scope and Market Size
Rare Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rare Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Originator Drugs
Generic Drugs

Segment by Application
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
F. Hoffmann-La Roche
Celgene
AbbVie
Johnson & Johnson
Takeda
Alexion
Novo Nordisk
Celgene
AbbVie
Amgen
Allergan
Eisai
Bristol-Myers Squibb
Merck
Vertex Pharmaceuticals
Baxter

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Originator Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Rare Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rare Disease Treatment Market Perspective (2016-2027)
2.2 Rare Disease Treatment Growth Trends by Regions
2.2.1 Rare Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rare Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Rare Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Rare Disease Treatment Industry Dynamic
2.3.1 Rare Disease Treatment Market Trends
2.3.2 Rare Disease Treatment Market Drivers
2.3.3 Rare Disease Treatment Market Challenges
2.3.4 Rare Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rare Disease Treatment Players by Revenue
3.1.1 Global Top Rare Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Rare Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Rare Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rare Disease Treatment Revenue
3.4 Global Rare Disease Treatment Market Concentration Ratio
3.4.1 Global Rare Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Treatment Revenue in 2020
3.5 Rare Disease Treatment Key Players Head office and Area Served
3.6 Key Players Rare Disease Treatment Product Solution and Service
3.7 Date of Enter into Rare Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Disease Treatment Breakdown Data by Type
4.1 Global Rare Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Rare Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Rare Disease Treatment Breakdown Data by Application
5.1 Global Rare Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Rare Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rare Disease Treatment Market Size (2016-2027)
6.2 North America Rare Disease Treatment Market Size by Type
6.2.1 North America Rare Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Rare Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Rare Disease Treatment Market Size by Type (2016-2027)
6.3 North America Rare Disease Treatment Market Size by Application
6.3.1 North America Rare Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Rare Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Rare Disease Treatment Market Size by Application (2016-2027)
6.4 North America Rare Disease Treatment Market Size by Country
6.4.1 North America Rare Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Rare Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Rare Disease Treatment Market Size (2016-2027)
7.2 Europe Rare Disease Treatment Market Size by Type
7.2.1 Europe Rare Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Rare Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Rare Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Rare Disease Treatment Market Size by Application
7.3.1 Europe Rare Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Rare Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Rare Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Rare Disease Treatment Market Size by Country
7.4.1 Europe Rare Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Rare Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rare Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Rare Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Rare Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rare Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rare Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Rare Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Rare Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rare Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rare Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Rare Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Rare Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rare Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rare Disease Treatment Market Size (2016-2027)
9.2 Latin America Rare Disease Treatment Market Size by Type
9.2.1 Latin America Rare Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Rare Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Rare Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Rare Disease Treatment Market Size by Application
9.3.1 Latin America Rare Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Rare Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Rare Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Rare Disease Treatment Market Size by Country
9.4.1 Latin America Rare Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Rare Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rare Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Rare Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Rare Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rare Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rare Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Rare Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Rare Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rare Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rare Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Rare Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Rare Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rare Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Rare Disease Treatment Introduction
11.1.4 Novartis Revenue in Rare Disease Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Rare Disease Treatment Introduction
11.2.4 Pfizer Revenue in Rare Disease Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Rare Disease Treatment Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Rare Disease Treatment Introduction
11.4.4 Celgene Revenue in Rare Disease Treatment Business (2016-2021)
11.4.5 Celgene Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Rare Disease Treatment Introduction
11.5.4 AbbVie Revenue in Rare Disease Treatment Business (2016-2021)
11.5.5 AbbVie Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Rare Disease Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Rare Disease Treatment Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Rare Disease Treatment Introduction
11.7.4 Takeda Revenue in Rare Disease Treatment Business (2016-2021)
11.7.5 Takeda Recent Development
11.8 Alexion
11.8.1 Alexion Company Details
11.8.2 Alexion Business Overview
11.8.3 Alexion Rare Disease Treatment Introduction
11.8.4 Alexion Revenue in Rare Disease Treatment Business (2016-2021)
11.8.5 Alexion Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Rare Disease Treatment Introduction
11.9.4 Novo Nordisk Revenue in Rare Disease Treatment Business (2016-2021)
11.9.5 Novo Nordisk Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Rare Disease Treatment Introduction
11.10.4 Sanofi Revenue in Rare Disease Treatment Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Rare Disease Treatment Introduction
11.11.4 Bayer Revenue in Rare Disease Treatment Business (2016-2021)
11.11.5 Bayer Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Rare Disease Treatment Introduction
11.12.4 Amgen Revenue in Rare Disease Treatment Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Rare Disease Treatment Introduction
11.13.4 Allergan Revenue in Rare Disease Treatment Business (2016-2021)
11.13.5 Allergan Recent Development
11.14 Eisai
11.14.1 Eisai Company Details
11.14.2 Eisai Business Overview
11.14.3 Eisai Rare Disease Treatment Introduction
11.14.4 Eisai Revenue in Rare Disease Treatment Business (2016-2021)
11.14.5 Eisai Recent Development
11.15 Bristol-Myers Squibb
11.15.1 Bristol-Myers Squibb Company Details
11.15.2 Bristol-Myers Squibb Business Overview
11.15.3 Bristol-Myers Squibb Rare Disease Treatment Introduction
11.15.4 Bristol-Myers Squibb Revenue in Rare Disease Treatment Business (2016-2021)
11.15.5 Bristol-Myers Squibb Recent Development
11.16 Merck
11.16.1 Merck Company Details
11.16.2 Merck Business Overview
11.16.3 Merck Rare Disease Treatment Introduction
11.16.4 Merck Revenue in Rare Disease Treatment Business (2016-2021)
11.16.5 Merck Recent Development
11.17 Vertex Pharmaceuticals
11.17.1 Vertex Pharmaceuticals Company Details
11.17.2 Vertex Pharmaceuticals Business Overview
11.17.3 Vertex Pharmaceuticals Rare Disease Treatment Introduction
11.17.4 Vertex Pharmaceuticals Revenue in Rare Disease Treatment Business (2016-2021)
11.17.5 Vertex Pharmaceuticals Recent Development
11.18 Baxter
11.18.1 Baxter Company Details
11.18.2 Baxter Business Overview
11.18.3 Baxter Rare Disease Treatment Introduction
11.18.4 Baxter Revenue in Rare Disease Treatment Business (2016-2021)
11.18.5 Baxter Recent Development
11.18 BioMarin
.1 BioMarin Company Details
.2 BioMarin Business Overview
.3 BioMarin Rare Disease Treatment Introduction
.4 BioMarin Revenue in Rare Disease Treatment Business (2016-2021)
.5 BioMarin Recent Development
11.20 Teva Pharmaceutical Industries
11.20.1 Teva Pharmaceutical Industries Company Details
11.20.2 Teva Pharmaceutical Industries Business Overview
11.20.3 Teva Pharmaceutical Industries Rare Disease Treatment Introduction
11.20.4 Teva Pharmaceutical Industries Revenue in Rare Disease Treatment Business (2016-2021)
11.20.5 Teva Pharmaceutical Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rare Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Originator Drugs
Table 3. Key Players of Generic Drugs
Table 4. Global Rare Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Rare Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rare Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Rare Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Rare Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Rare Disease Treatment Market Share by Regions (2022-2027)
Table 10. Rare Disease Treatment Market Trends
Table 11. Rare Disease Treatment Market Drivers
Table 12. Rare Disease Treatment Market Challenges
Table 13. Rare Disease Treatment Market Restraints
Table 14. Global Rare Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Rare Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Rare Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Treatment as of 2020)
Table 17. Ranking of Global Top Rare Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Rare Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rare Disease Treatment Product Solution and Service
Table 21. Date of Enter into Rare Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Rare Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Rare Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Rare Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Rare Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Rare Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Rare Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Rare Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Rare Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Rare Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Rare Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Rare Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Rare Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Rare Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Rare Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Rare Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Rare Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Rare Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Rare Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Rare Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Rare Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Rare Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rare Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rare Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rare Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Rare Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Rare Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Rare Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Rare Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Rare Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Rare Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Rare Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Rare Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Rare Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rare Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rare Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rare Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Rare Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Rare Disease Treatment Product
Table 64. Novartis Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Rare Disease Treatment Product
Table 69. Pfizer Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. F. Hoffmann-La Roche Company Details
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche Rare Disease Treatment Product
Table 74. F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Celgene Company Details
Table 77. Celgene Business Overview
Table 78. Celgene Rare Disease Treatment Product
Table 79. Celgene Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Celgene Recent Development
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Rare Disease Treatment Product
Table 84. AbbVie Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Rare Disease Treatment Product
Table 89. Johnson & Johnson Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Takeda Company Details
Table 92. Takeda Business Overview
Table 93. Takeda Rare Disease Treatment Product
Table 94. Takeda Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Takeda Recent Development
Table 96. Alexion Company Details
Table 97. Alexion Business Overview
Table 98. Alexion Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 99. Alexion Recent Development
Table 100. Novo Nordisk Company Details
Table 101. Novo Nordisk Business Overview
Table 102. Novo Nordisk Rare Disease Treatment Product
Table 103. Novo Nordisk Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 104. Novo Nordisk Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Rare Disease Treatment Product
Table 108. Sanofi Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Bayer Company Details
Table 111. Bayer Business Overview
Table 112. Bayer Rare Disease Treatment Product
Table 113. Bayer Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 114. Bayer Recent Development
Table 115. Amgen Company Details
Table 116. Amgen Business Overview
Table 117. Amgen Rare Disease Treatment Product
Table 118. Amgen Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 119. Amgen Recent Development
Table 120. Allergan Company Details
Table 121. Allergan Business Overview
Table 122. Allergan Rare Disease Treatment Product
Table 123. Allergan Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 124. Allergan Recent Development
Table 125. Eisai Company Details
Table 126. Eisai Business Overview
Table 127. Eisai Rare Disease Treatment Product
Table 128. Eisai Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 129. Eisai Recent Development
Table 130. Bristol-Myers Squibb Company Details
Table 131. Bristol-Myers Squibb Business Overview
Table 132. Bristol-Myers Squibb Rare Disease Treatment Product
Table 133. Bristol-Myers Squibb Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 134. Bristol-Myers Squibb Recent Development
Table 135. Merck Company Details
Table 136. Merck Business Overview
Table 137. Merck Rare Disease Treatment Product
Table 138. Merck Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 139. Merck Recent Development
Table 140. Vertex Pharmaceuticals Company Details
Table 141. Vertex Pharmaceuticals Business Overview
Table 142. Vertex Pharmaceuticals Rare Disease Treatment Product
Table 143. Vertex Pharmaceuticals Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 144. Vertex Pharmaceuticals Recent Development
Table 145. Baxter Company Details
Table 146. Baxter Business Overview
Table 147. Baxter Rare Disease Treatment Product
Table 148. Baxter Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 149. Baxter Recent Development
Table 150. BioMarin Company Details
Table 151. BioMarin Business Overview
Table 152. BioMarin Rare Disease Treatment Product
Table 153. BioMarin Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 154. BioMarin Recent Development
Table 155. Teva Pharmaceutical Industries Company Details
Table 156. Teva Pharmaceutical Industries Business Overview
Table 157. Teva Pharmaceutical Industries Rare Disease Treatment Product
Table 158. Teva Pharmaceutical Industries Revenue in Rare Disease Treatment Business (2016-2021) & (US$ Million)
Table 159. Teva Pharmaceutical Industries Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Originator Drugs Features
Figure 3. Generic Drugs Features
Figure 4. Global Rare Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Specialty Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Rare Disease Treatment Report Years Considered
Figure 9. Global Rare Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Rare Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Rare Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Rare Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Rare Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Rare Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Rare Disease Treatment Revenue in 2020
Figure 16. Global Rare Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Rare Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Rare Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Rare Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Rare Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rare Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Rare Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Rare Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rare Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Rare Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Rare Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rare Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Rare Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Rare Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rare Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Rare Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Rare Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Rare Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 60. Celgene Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 64. Alexion Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 65. Novo Nordisk Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 69. Allergan Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 70. Eisai Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 73. Vertex Pharmaceuticals Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 74. Baxter Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 75. BioMarin Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 76. Teva Pharmaceutical Industries Revenue Growth Rate in Rare Disease Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---